Product Name: Human DC-SIGN / CD209 Antibody (INSERM patent anti-DC-SIGN, Research Use)
Catalog Number: NBR-0472
Target Name: DC-SIGN / CD209
Trade Name: INSERM patent anti-DC-SIGN
Antibody Drug Description: The drug is a recombinant fully human anti-DC-SIGN monoclonal antibody, being developed by INSERM. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: CD209
Synonyms: CDSIGN; CLEC4L; DC-SIGN; DC-SIGN1
Target Description: Pathogen-recognition receptor expressed on the surface of immature dendritic cells (DCs) and involved in initiation of primary immune response. Thought to mediate the endocytosis of pathogens which are subsequently degraded in lysosomal compartments.
Ensembl:  ENSG00000090659
Uniprot:  Q9NNX6